SPEECHMATICS LIMITED

Speechmatics is a privately held technology company specializing in automatic speech recognition (ASR) and voice artificial intelligence (AI). Founded in 2006, the company's core mission is to "Understand Every Voice," providing inclusive and accurate speech technology solutions. Headquartered in Cambridge, United Kingdom, Speechmatics aims to unlock the business value in human speech for enterprises globally.

The company offers a comprehensive suite of products and services, including real-time and batch Speech-to-Text (STT), Text-to-Speech (TTS), and Voice AI infrastructure. Its technology leverages advanced machine learning and AI to provide highly accurate transcriptions across more than 55 languages and various dialects, regardless of demographic, age, gender, or accent. Key features include speaker diarization, sentiment analysis, summarization, topic detection, and translation. Speechmatics' solutions are deployable via Cloud API, on-premises, on-device, and through edge/hybrid environments, catering to diverse market segments such as media and broadcast, contact centers, healthcare, education, legal, finance, and AI infrastructure.

Led by CEO Katy Wigdahl, Speechmatics has maintained a strong market position through continuous innovation and strategic partnerships. Recent notable developments include the launch of a next-generation Medical Speech-to-Text model in September 2025, achieving 93% accuracy for clinical transcription, and a partnership with Boost.ai in February 2026 to enhance enterprise Voice AI deployment. In March 2026, Speechmatics introduced a groundbreaking Arabic–English bilingual medical model, capable of handling code-switching and diverse dialects. The company also partnered with Sully.ai in January 2026 to power autonomous healthcare agents and scribes. Speechmatics' on-device deployment has reached production scale, with millions of users leveraging its technology locally for applications ranging from media editing to medical scribing.